NASDAQIndustrialsAgricultural - MachinerySnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for ARTW yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Gross profit improvement to maintain or exceed Q1 2026 level | Gross profit nearly doubled from $944K to $1.91M. | Improving | gross profit falls below $944K in any quarter next year | Gross profit: $1.66M FY2026-Q3; GAAP. Published target: >= $1.91 million in next 4 quarters. Target period is not explicitly aligned with this observation. Oct 13, 20261,660,490 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
ARTW is a small industrial business with growth progress but elevated execution risk, rather than a proven durable compounder. Its long-term thesis is on watch: revenue and backlog are advancing, but earnings remain loss-making and confidence is medium.
The evidence describes ARTW as cheap versus peers, with a near-neutral expectations gap. The valuation signal is medium confidence, and no fragility gates are flagged, so the evidence does not point to unusually concentrated market expectations.
In the near term, revenue growth and a sharp rise in Modular Buildings backlog show progress, but consolidated gross margin declined and segment margin results were mixed. Earnings risk is elevated, with a stated 65% chance of a next-quarter miss; a guidance cut would be a meaningful negative. Over the multi-year view, execution on backlog and margin recovery matters, while recent performance remains below the industry cohort.
The thesis depends on whether ARTW can convert Modular Buildings commitments into sales and improve margins amid cost pressure. Near-term results also hinge on guidance and earnings execution. Strength or weakness among industrial bellwethers such as CAT, DE, and CNH could affect the sector backdrop.
Over the next one to three years, ARTW has evidence of growth progress, but loss-making results, margin challenges, and elevated near-term earnings risk leave the long-term thesis uncertain. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 3 of 3 supplied quarters. Management reported: “In both segments we are battling rising material and operating costs that have put pressure on margins.” “We are actively working to regain margin in both businesses while continuing to grow in the markets we serve.”
Positive cash flow from operations sustained | Cash flow from operations turned positive from negative $889K to $148K. | Improving | cash flow from operations falls below $0 in any quarter next year | Cash from operations: $1.338M FY2026-Q3; GAAP. Published target: >= $0 in next 4 quarters. Target period is not explicitly aligned with this observation. Oct 13, 20261,337,812 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth to sustain above prior quarter level | A primary condition in ARTS WAY MANUFACTURING CO INC's published investment case. The stated target is >= $6.64 million in next 4 quarters. | Intact | revenue falls below $5.07 million in any quarter next year | Revenue: $5.615M FY2026-Q3; GAAP. Published target: >= $6.64 million in next 4 quarters. Target period is not explicitly aligned with this observation. Oct 13, 20265,615,156 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 3 supplied quarters. Management reported: “We continue to be pleased with the strong demand for livestock equipment we’ve experienced for much of the year, resulting in Agricultural Equipment sales that remain ahead of 2025 levels.” “Our grinder mixer sales increased approximately $1,523,000 year-on-year.” Revenue was $5.615 million in 2026-Q3. Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.